QUANTIB® Prostate

Read prostate MRI at expert level supported by AI

Quantib® Prostate is here to help you manage the increase in prostate MRI workload and streamline the radiology workflow.
The FDA cleared and CE marked zero-footprint artificial intelligence-based software provides a workflow for the detection of abnormalities on MRI prostate scans. 
HubSpot Video

Man with prostate cancer schematic drawing Yearly, 1.3M men are diagnosed with prostate cancer, often without the use of MRI, while NEJM and The Lancet report strong benefits of MRI.1,2

Prostate cancer MRI guidelines illustrative figure New guidelines adopted by EAU and ACR advise to include MRI prior to all 3M biopsies taken yearly in Europe and the United States.3,4

Prostate cancer MRI increased workload illustrative figure Radiology practices already see a doubling in case load of multiparametric MRI prostate scans.

1 Taneja, S. S. et al. MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis. N. Engl. J. Med. 378, 1767–1777 (2018).
2 Ahmed, H. U. et al. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet 389, 815–822.
3 Andrew B. Rosenkrantz, M. et al. ACR - Prostate MRI Model Policy. Available at: https://www.acr.org/-/media/ACR/Files/Advocacy/AIA/Prostate-MRI-Model-Policy72219.pdf. (Accessed: 7th May 2020)
4 Mottet, N. et al. European Association of Urology - Prostate Cancer. 2020 Available at: https://uroweb.org/guideline/prostate-cancer/. (Accessed: 7th May 2020)

Infographic pathway horizontal (2000 × 800 px)

 

What if you could have...

One solution,
one workflow

No more switching between PACS, PSA density calculation feature and PI-RADS support; Quantib® Prostate offers one workflow including all essential prostate MRI reading features.

AI-based support for
lesion assessment

Semi-automated combination of bi-parametric data supports ROI determination and enables prostate lesion evaluation. AI-bolstered segmentation allows for easy and fast determination of lesion volume.

Click-of-a-button
reporting

After prostate MRI assessment, a customized report is created including PSA density, quantified volumes, PI-RADS v.2.1 scoring and key images of suspicious regions. 

Product overview

Key features include

  • AI-driven prostate segmentation, volume measurements and integrated automatic PSA density calculation
  • Fast, AI-supported ROI segmentation of suspicious areas
  • Visual PI-RADS v.2.1 scoring support
  • Export of prostate gland segmentation, ROIs and standardized report to PACS and compatible ultrasound systems*
  • A structured report including key images and visual representation of PI-RADS v.2.1 results
  • Kinetic curve representation per ROI and of the full prostate gland
Learn More
QPR 1.3 - Cropped mock up-1

Quantib® Prostate is currently 510(k) cleared by the FDA for distribution in the US. This product complies with all applicable requirements of the European MDR (2017/745). Availability in EU countries upon request. Not commercially available in other countries.

* For more information about the product's compatibility with ultrasound systems, please contact us

Customer experience using Quantib® Prostate

Edward Steiner, MD | The York/WellSpan Advanced Prostate Care Center

"Quantib® Prostate is much more helpful than I would have ever imagined given all the buzz about AI. But this buzz is real, this is trully a nice product."

Read more about his experience with Quantib® Prostate

Martina Martins, MD | Swiss International Prostate Center

"Quantib® Prostate helped me decrease my reporting times significantly, so I can get more cases done in a day. Additionally, the ease-of-use of Quantib® Prostate makes the software a joy to work with."

Read more about her experience with Quantib® Prostate

Do you want to learn more about Quantib® Prostate? 

Learn more from our resources

AI in prostate cancer - homepage image

The Ultimate Guide to AI in Prostate Cancer

How does artificial intelligence work? What are promising AI applications in the prostate cancer pathway? Which solutions are available now?

Read more

QPR thumbnail resource page

Quantib® Prostate White Paper

Download the white paper to discover how to improve the clinical pathway of prostate cancer with AI and our solution: Quantib® Prostate. 

Access the white paper

210713 - SM pain points-1

AI can help minimize radiologist's biggest challenges

Read the article to discover how AI can help radiologist's overcome the most common challenges associated with prostate MRI.  

Read the article